Patents by Inventor Ilya Shestopalov

Ilya Shestopalov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220325336
    Abstract: Disclosed herein are lentiviral vector transduction efficiency assays for gene therapy treatments. Also disclosed herein are methods for measuring transduction efficiency of a lentiviral vector.
    Type: Application
    Filed: September 7, 2020
    Publication date: October 13, 2022
    Inventor: Ilya Shestopalov
  • Publication number: 20220163512
    Abstract: Disclosed herein are potency assays for a gene therapy treatment for ?-thalassemia. Also disclosed herein are methods for measuring relative potency of a drug product.
    Type: Application
    Filed: March 27, 2020
    Publication date: May 26, 2022
    Applicant: bluebird bio, Inc.
    Inventors: ILYA SHESTOPALOV, MELISSA BONNER
  • Publication number: 20220154145
    Abstract: Disclosed herein are potency assays for a gene therapy treatment for sickle cell disease. Also disclosed herein are methods for measuring relative potency of a drug product used for the treatment of sickle cell disease.
    Type: Application
    Filed: March 20, 2020
    Publication date: May 19, 2022
    Applicant: bluebird bio, Inc.
    Inventors: ILYA SHESTOPALOV, MELISSA BONNER, GRETCHEN AMBERLEA MAI LEWIS
  • Publication number: 20130066059
    Abstract: A bifunctional and photocleavable linker for cyclizing a morpholino-based oligonucleotide, having the formula: with the Linker as a photoactive group derivatized spacer molecule that presents two functional groups for cyclizing a selected morpholino and with the R group as a photoactive group utilized in the process of photocleavage and the X and Z groups are functional groups utilized for attachment to a morpholino to generate a cyclic structure.
    Type: Application
    Filed: August 23, 2012
    Publication date: March 14, 2013
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: JAMES K. CHEN, ILYA A. SHESTOPALOV, SAYUMI YAMAZOE
  • Publication number: 20110178281
    Abstract: Bifunctional linkers are provided that comprise a photocleavable moiety flanked by two different amine reactive moieties. In some embodiments the photocleavable moiety is a dimethoxynitrobenzyl moiety. In other embodiments the photocleavable moiety is 8-bromo-7-hydroxyquinoline. In other embodiments the photocleavable moiety is nitrodibenzofuran. In other embodiments the photocleavable moiety is 6-bromo-7-hydroxycoumarin-4-ylmethyl. The linkers find use in synthetic methods, including the generation of photocleavable oligonucleotides, e.g. caged morpholinos.
    Type: Application
    Filed: March 16, 2011
    Publication date: July 21, 2011
    Inventors: James K. Chen, Surajit Sinha, Ilya Shestopalov, Xiaohu Ouyang
  • Patent number: 7923562
    Abstract: Bifunctional linkers are provided that comprise a photocleavable moiety flanked by two different amine reactive moieties. In some embodiments the photocleavable moiety is a dimethoxynitrobenzyl moiety. In other embodiments the photocleavable moiety is 8-bromo-7-hydroxyquinoline. In other embodiments the photocleavable moiety is nitrodibenzofuran. In other embodiments the photocleavable moiety is 6-bromo-7-hydroxycoumarin-4-ylmethyl. The linkers find use in synthetic methods, including the generation of photocleavable oligonucleotides, e.g. caged morpholinos.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: April 12, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James K. Chen, Surajit Sinha, Ilya Shestopalov, Xiaohu Ouyang
  • Publication number: 20100022761
    Abstract: Bifunctional linkers are provided that comprise a photocleavable moiety flanked by two different amine reactive moieties. In some embodiments the photocleavable moiety is a dimethoxynitrobenzyl moiety. In other embodiments the photocleavable moiety is 8-bromo-7-hydroxyquinoline. In other embodiments the photocleavable moiety is nitrodibenzofuran. In other embodiments the photocleavable moiety is 6-bromo-7-hydroxycoumarin-4-ylmethyl. The linkers find use in synthetic methods, including the generation of photocleavable oligonucleotides, e.g. caged morpholinos.
    Type: Application
    Filed: June 16, 2009
    Publication date: January 28, 2010
    Inventors: James K. Chen, Surajit Sinha, Ilya Shestopalov, Xiaohu Ouyang